$AVEO Company News Aveo loss widens on revenue d
Post# of 44803
![Avatar](/images/ProfileImages/410421673_9050_Stock_Tracker.jpg)
Aveo loss widens on revenue drop; shares down 8:48 a.m. April 30, 2013 - MarketWatch.com
Updates, advisories and surprises 4:01 p.m. Aug. 2, 2012 - MarketWatch
Thursday’s biggest gaining and declining stocks 12:11 p.m. Aug. 2, 2012 - MarketWatch
Aveo sinks 27% after FDA update, earnings 10:57 a.m. Aug. 2, 2012 - Val Brickates Kennedy
Aveo dives 25% on FDA update 9:57 a.m. Aug. 2, 2012 - Val Brickates Kennedy
Dividends don't lie 8:51 a.m. Jan. 9, 2012 - The Trading Deck
Aveo cancer treatment meets goal, but shares drop 2:43 p.m. Jan. 3, 2012 - MarketWatch.com
Aveo reports progress with cancer-drug candidate 6:58 a.m. Jan. 3, 2012 - MarketWatch.com
Updates, advisories and surprises 4:31 p.m. July 28, 2011 - MarketWatch
AVEO climbs on earnings, outlook 11:18 a.m. July 28, 2011 - Val Brickates Kennedy
Wednesday’s biggest gaining and declining stocks 3:46 p.m. June 15, 2011 - Kate Gibson
Regeneron energizes biotech stocks 2:37 p.m. June 15, 2011 - Val Brickates Kennedy
AVEO shares tumble 10% on stock offer pricing 9:19 a.m. June 15, 2011 - Val Brickates Kennedy
Inspire, AVEO take lead in drug-stocks trading 3:14 p.m. Feb. 17, 2011 - Val Brickates Kennedy
AVEO shares jump on Astellas pact 11:04 a.m. Feb. 17, 2011 - Val Brickates Kennedy
Biotech 2013 By The Numbers: A Blockbuster Year 9:13 a.m. Jan. 1, 2014 - TheStreet.com
AVEO Pharmaceuticals, Inc. (AVEO) Catches Eye: Stock Rises 8% - Tale of the Tape 8:44 a.m. Dec. 31, 2013 - Zacks.com
Chelsea: FDA Panel Meeting And Trading Strategies 4:34 p.m. Dec. 30, 2013 - Seeking Alpha
The Worst Biotech CEO of 2013 Is... 7:58 a.m. Dec. 17, 2013 - TheStreet.com
AVEO Falls on Tivozanib News - Analyst Blog 6:20 p.m. Dec. 16, 2013 - Zacks.com
Monday's healthcare upgrades, downgrades, and initiations 9:49 a.m. Dec. 16, 2013 - Seeking Alpha
Aveo says lead drug unlikely to succeed in colon cancer study, -15% 11:06 a.m. Dec. 13, 2013 - Seeking Alpha
AVEO Says Tivozanib Trial in Colorectal Cancer Unlikely to Meet Primary Endpoint 5:53 a.m. Dec. 13, 2013 - benzinga.com
Your Vote Counts: Who is the Worst Biotech CEO of 2013? 8:32 a.m. Dec. 12, 2013 - TheStreet.com
Tracking Seth Klarman's Baupost Group Holdings - Q3 2013 Update 12:24 a.m. Nov. 14, 2013 - Seeking Alpha
AVEO Q3 Loss Wider than Expected, Shares Down - Analyst Blog 9:30 a.m. Nov. 12, 2013 - Zacks.com
10-Q: AVEO PHARMACEUTICALS INC 6:33 a.m. Nov. 7, 2013 - Edgar Online - (EDG = 10Q, 10K)
Karyopharm Therapeutics IPO Looks Promising 7:44 a.m. Nov. 6, 2013 - Seeking Alpha
Wild Card Wonders, Shopping for 52-Week Lows 9:04 p.m. Sept. 28, 2013 - GuruFocus.com
Sleepy Sector Wakes Up - Billionaires Hold Biotechs in 52-week Low 12:52 p.m. Sept. 3, 2013 - GuruFocus.com
Looking At AVEO With Fresh Eyes 9:47 a.m. Aug. 29, 2013 - Seeking Alpha
5 Stupidest Small-Cap Stock Investments 3:29 a.m. Aug. 27, 2013 - InvestorPlace.com
9 Compelling Reasons To Buy Opexa Therapeutics Right Now 11:44 a.m. Aug. 15, 2013 - Seeking Alpha
Cutting Loose: Seth Klarman's Active Second Quarter Selling and Trimming 5:51 p.m. Aug. 14, 2013 - GuruFocus.com
Tracking Seth Klarman's Baupost Group Holdings - Q2 2013 Update 11:57 a.m. Aug. 14, 2013 - Seeking Alpha
Annual Changes to the NASDAQ Biotechnology Index 8:05 a.m. Dec. 16, 2013 - GlobeNewswire
AVEO Provides Update on Interim Analysis from Tivozanib Trial in Colorectal Cancer 6:50 a.m. Dec. 13, 2013 - BusinessWire
AVEO Reports Third Quarter 2013 Financial Results 6:32 a.m. Nov. 7, 2013 - BusinessWire
Flagship VentureLabs Launches Midori Renewables 12:18 p.m. Sept. 4, 2013 - PR Newswire
AVEO Oncology to Present at the Morgan Stanley Global Healthcare Conference 5:30 a.m. Sept. 4, 2013 - BusinessWire
The World Economic Forum Recognizes Four Flagship Ventures Portfolio Companies as Technology Pioneers for 2014 2:48 p.m. Aug. 28, 2013 - PR Newswire
AVEO Oncology to Present at the Canaccord Genuity 33rd Annual Growth Conference 5:30 a.m. Aug. 9, 2013 - BusinessWire
AVEO Reports Second Quarter 2013 Financial Results 5:30 a.m. Aug. 8, 2013 - BusinessWire
Five Star Equities Issues New Research Reports on ATHN, AVEO, EW and QSII 7:43 a.m. July 15, 2013 - ACCESSWIRE
Pomerantz Law Firm Reminds Shareholders With Losses on Their Investment in Aveo Pharmaceuticals, Inc. of Class Action Lawsuit and Upcoming Deadline -- AVEO 9:24 a.m. July 7, 2013 - GlobeNewswire
Pomerantz Law Firm Reminds Shareholders With Losses on Their Investment in Aveo Pharmaceuticals, Inc. of Class Action Lawsuit and Upcoming Deadline -- AVEO 12:48 p.m. June 28, 2013 - GlobeNewswire
DEADLINE ALERT: Rigrodsky & Long, P.A. Reminds Shareholders of AVEO Pharmaceuticals, Inc. of Upcoming Deadline 4:22 p.m. June 25, 2013 - BusinessWire
Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses in Excess of $100,000 Investing in AVEO Pharmaceuticals, Inc. to Contact the Firm -- AVEO 4:00 p.m. June 25, 2013 - GlobeNewswire
Law Offices of Todd M. Garber Announces Lead Plaintiff Deadline In The Class Action Lawsuit Against AVEO Pharmaceuticals, Inc. 7:41 p.m. June 24, 2013 - BusinessWire
Flagship Ventures Kicks-off its VentureLabs(TM) Entrepreneurial Fellowship Program 8:15 a.m. June 20, 2013 - PR Newswire
Glancy Binkow & Goldberg Announces Lead Plaintiff Deadline In The Class Action Lawsuit Against AVEO Pharmaceuticals, Inc. 8:32 a.m. June 17, 2013 - BusinessWire
Pomerantz Law Firm Reminds Shareholders With Losses on Their Investment in Aveo Pharmaceuticals, Inc. of Class Action Lawsuit and Upcoming Deadline -- AVEO 3:19 p.m. June 14, 2013 - GlobeNewswire
Law Offices of Todd M. Garber Announces Class Action Lawsuit Against AVEO Pharmaceuticals, Inc. 2:27 p.m. June 12, 2013 - BusinessWire
AVEO Announces Complete Response Letter Received for Tivozanib New Drug Application in Renal Cell Carcinoma 5:30 a.m. June 10, 2013 - BusinessWire
AVEO Oncology Announces Strategic Restructuring 3:30 p.m. June 4, 2013 - BusinessWire
![Like This Post](/images/thumb-up.png)
![Dislike This Post](/images/thumb-down.png)